Published: 02.09.2020
References:
- Batushkin V.V., Inh R.T. (2016) Moduliatsiia systemy hamma-aminomaslianoi kyslotyy pid vplyvom ekstraktu pasyflory inkarnatu, vidnovlennia pokaznykiv vehetatyvnoi rivnovahy ta harmonizatsiia funktsionuvannia tserebralnykh i pidkirkovykh struktur u khvorykh z arterialnoiu hipertenziieiu zhinochoi stati. Kardyolohyia, 5–6: 1–11.
- Bulavenko O.B. (2008) Nedostatnist liuteinovoi fazy: klinika, diahnostyka ta likuvannia: Avtoref. dys. … d-ra med. nauk: spets. 14.01.01. «Akusherstvo ta hinekolohiia». DU «IPAH NAMN Ukrainy», Kyiv, 37 s.
- Burchinskiy S.G. (2001) Sovremennyie snotvornyie sredstva. VIsn. farmakol. farm., 1–2: 27–32.
- Burchinskiy S.G. (2008) Trevozhnyie rasstroystva v obschemeditsinskoy i nevrologicheskoy praktike: problemyi farmakoterapii. Rats. farmakoter., 4: 43–47.
- Dyukova G.M. (2001) Kachestvo zhizni zhenschinyi v period klimakteriya. Lech. vrach, 1: 3–6.
- Katasonov A.B. (2018) Neyrobiologicheskie effektyi teanina i ego vozmozhnoe ispolzovanie v nevrologii i psihiatrii. nevrol. psihiatr., 118(11): 118–124.
- Kostyuchenko S.I. (2008) Epidemiologiya psihicheskogo zdorovya v Ukraine. NeyroNews, 2: 9–13.
- Marchenko L.A. (2000) Zheltoe telo. Mehanizmyi formirovaniya i regressa. Ginekol. prakt. vrachey, 5(2): 23–25.
- Prilepskaya V.N., Mezhevitinova E.A. (2005) Predmenstrualnyiy sindrom. Consilium Medicum. Ginekologiya, 7(4): 28–34.
- Sidelnikova B.M. (2005) Privyichnaya poterya beremennosti. Moskva, 303.
- Smulevich A.B. (2016) Psihosomaticheskie rasstroystva (klinika, terapiya, organizatsiya meditsinskoy pomoschi). Psihiat. psihofarmakoter., 12(2): 35–51.
- Syunyakov T.S., Syunyakov S.A., Dorofeeva O.F. (2011) Mehanizmyi anksiogeneza i terapiya trevogi. Consilium Med., 6: 82–89.
- Tatarchuk T.F., Kosey N.V., Tutchenko T.N. (2016) Lechenie stress-indutsirovannoy nedostatochnosti lyuteinovoy fazyi. Zdorove zhenschinyi, 3: 18–23.
- Hitrov N.K., Saltyikov A.B. (2003) Bolezni tsivilizatsii i nozologicheskiy printsip meditsinyi s pozitsiy obschey patologii. Klin. med., 1: 5–11.
- Chaban O.S., Khaustova O.O. (2020) Tryvoha u patsiientiv ikh khronichnymy neinfektsiinymy zakhvoriuvanniamy: subklinichni ta psykhosomatychni oznaky, diahnostyka, terapiia. NeiroNews, 3: 38–44.
- Accorti E.E., Wong M.S. (2017) It is time for routine screening for perinatal mood and anxiety disorders in obstetrics and gynecology settings. Obstet. Gynecol. Surv., 72: 553–568.
- Appleton J.K. (2012) Hypnotics: past, presence, future. Modern Neuropsychopharmacology. Illinois Univ. Press, Chicago, Vol. 4, р. 164–198.
- Birkhaueser M., Genazzani A.R. (Eds.) (2018) Pre-menopausal, menopause and beyond: vol. 5: Frontiers in gynecological endocrinology. Cham, Springer, 326 p.
- Bryant C., Kleinstauber M., Judd H. (2014) Aspects of mental health care in the gynecological setting. Women’s Health, 10: 237–254.
- Burk J.D., Regier D.A. (1994) Epidemiology of mental disorders. Textbook of Psychiatry. Am. Psychiatr. Press, N.Y., р. 67–89.
- Chandrasekhar K., Kapoor J., Anishetty S. (2012) A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J. Psychol. Med., 34(3): 255–262. doi: 10.4103/0253-7176.106022.
- Cohen L.S. (2005) Diagnosis and management of mood disorders during the menopausal transition. Am. J. Med.,118: 93S—97S.
- Cornblatt D.J., Peters A.M., De Souza A. (2004) Use of psychotropic drugs in general practice. Psychiatric Aspects in General Medicine. Illinois Univ. Press, Chicago, р. 235–244.
- Devoto L. (2000) The human corpus luteum: life cycle and function in natural cycles. Fertil Steril., 02(3): 1067–1070.
- Freeman E.W., Sondheimer S.J. (2003) Premenstrual dysphoric disorder: recognition and treatment. J. Clin. Psychiat., 5: 30–39.
- Haskell C.F., Kennedy D.O., Milne A.L. et al. (2008) The effects of L-theanine, caffeine and their combination on cognition and mood. Biol. Psychiat., 77: 113–122.
- Henderson V.W. (2005) Menopause and disorders of the central nervous system. Minerva Ginecol., 57: 579–592.
- Hidese S., Ota M., Wakabayashi C. et al. (2017) Effects of chronic L-theanine administration in patients with major depressive disorder: an open-label study. Acta Neuropsychiat., 29: 72–79.
- Jaysing Salve et al. (2019) Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clin. Study. Cureus, 11(12): e6466. doi: 10.7759/cureus.6466.
- Kulkarni S.K., Dhir A. (2008) Withania somnifera: an Indian ginseng. Progr. Neuropsychopharmacol Biol. Psychiat., 32: 1093–1105.
- Kumar A., Kalonia H. (2008) Effect of Withania somnifera on sleep-wake cyclt in sleep-disturbed rats: possible GABA-ergic mechanism. Ind. J. Pharm. Res., 8: 806–812.
- Leddy M.A., Lawrence H., Schulkin J. (2011) Obstetrician-gynecologists and women’s mental health: findings of the collaborative ambulatory research network 2005–2009. Obstet. Gynecol. Surv., 66: 316–323.
- Louik C. (2007) First-trimester yse of selective serotonin-reuptake inhibitors and the risk of birth defects. N. Eng. J. Med., 172: 57–59.
- McCabe S. (2002) Complimentary herbal and alternative drugs in clinical practice. Perspect. Psychiat. Care, 38: 98–107.
- Miroddi M., Calapai G. et al. (2013) Passiflora incarnate L.: ethnopharmacology, clinical application, safety and evaluation of clinical trials. J. Ethnopharmacol., 150: 791–804.
- Pratte M.A., Nanavati K.B. (2014) An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb Ashwagandha (Withania somnifera). J. Alternat. Comparat. Med., 20: 901–908.
- Williams J., Everett J.M., D’Cunha N.M., Sergi D. (2020) The Effects of Green Tea Amino Acid L-Theanine Consumption on the Ability to Manage Stress and Anxiety Levels: a Systematic Review. Plant Foods Hum. Nutr., 75(1): 12–23.